Posted: Feb 22, 2022
API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy Council
Read moreabout API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy CouncilPosted: Feb 18, 2022
February 2022 newsletter
Hi Everyone, We hope you’re having a great February and looking forward to spending some quality time with your family…
Read moreabout February 2022 newsletterPosted: Feb 18, 2022
Govt of Alberta announces of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group
Read moreabout Govt of Alberta announces of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working GroupPosted: Feb 11, 2022
Archana Koul, Scientist, API: Interacting with the life sciences industry
In this video, Archana Koul, Scientist (S1) shares her experience of working…
Read moreabout Archana Koul, Scientist, API: Interacting with the life sciences industryPosted: Feb 3, 2022
Canurta Inc. announces partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta for novel hemp polyphenols-based drug discoveries
Read moreabout Canurta Inc. announces partnership with Applied Pharmaceutical Innovation (API) and Dr. Neal M. Davies of University of Alberta for novel hemp polyphenols-based drug discoveriesPosted: Feb 2, 2022
Jade Alberts interviews Andrew MacIsaac, CEO at API for his show ‘Telling it Like It Is’
Read moreabout Jade Alberts interviews Andrew MacIsaac, CEO at API for his show ‘Telling it Like It Is’Posted: Jan 26, 2022
January 2022 newsletter
Hi Everyone, We hope you all had a great holiday, a restorative break and a good start to the new…
Read moreabout January 2022 newsletterPosted: Jan 13, 2022
Bringing talent and expertise into Alberta by way of investment attraction: Jason Pincock
Read moreabout Bringing talent and expertise into Alberta by way of investment attraction: Jason PincockPosted: Jan 3, 2022
Applied Pharmaceutical Innovation (API) CEO Andrew MacIssac awarded with a 2022 Edifier Award.
Read moreabout Applied Pharmaceutical Innovation (API) CEO Andrew MacIssac awarded with a 2022 Edifier Award.Posted: Dec 22, 2021
December 2021 newsletter
Newsletter Header December 2021 Hi Everyone, Happy (almost) end of 2021! We started the year by focusing on keeping the…
Read moreabout December 2021 newsletterPosted: Dec 10, 2021
Creating opportunities for talent retention: Jason Pincock, Board Member, API and CEO, DynaLIFE
Read moreabout Creating opportunities for talent retention: Jason Pincock, Board Member, API and CEO, DynaLIFEPosted: Dec 8, 2021
Inviting all start-up entrepreneurs and innovators seeking to raise $1 million in seed-stage funding – Life Sciences Investment Summit 2022
Read moreabout Inviting all start-up entrepreneurs and innovators seeking to raise $1 million in seed-stage funding – Life Sciences Investment Summit 2022Posted: Dec 1, 2021
The Government of Alberta announces $5.6 million in funding to Applied Pharmaceutical Innovation for the Canadian Critical Drug Initiative (CCDI)
Read moreabout The Government of Alberta announces $5.6 million in funding to Applied Pharmaceutical Innovation for the Canadian Critical Drug Initiative (CCDI)Posted: Nov 16, 2021
November 2021 newsletter
Hi Everyone, In our last newsletter, we shared our plan to establish significant manufacturing capacity in Alberta to ensure Canadians will…
Read moreabout November 2021 newsletterPosted: Nov 2, 2021
U of A-industry partnership poised to close Canada’s drug supply gaps
Read moreabout U of A-industry partnership poised to close Canada’s drug supply gapsPosted: Nov 1, 2021